Evidence map›Paper›PMID 30206344›Full record

ArticleNature reviews. Microbiology2018

Author Correction: Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.

Mark C Field, David Horn, Alan H Fairlamb, Michael A J Ferguson, David W Gray, Kevin D Read, Manu De Rycker, Leah S Torrie, Paul G Wyatt, Susan Wyllie and 1 more

Open access · greenAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mark C FieldWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
David HornWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Alan H FairlambWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Michael A J FergusonWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
David W GrayWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Kevin D ReadWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Manu De RyckerWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Leah S TorrieWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Paul G WyattWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Susan WyllieWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK.
Ian H GilbertWellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, DD1 5EH, UK. i.h.gilbert@dundee.ac.uk.
University of Dundee · GBWellcome Centre for Anti-Infectives Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structures of nifurtimox in Table 1 were incorrect and have been updated in the pdf and online. The authors apologize for any confusion caused.

Identifiers

PMID30206344
OpenAlexW2889868490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.